Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy

SIMPLE SUMMARY: Boron neutron capture therapy (BNCT) is a non-invasive therapeutic technique for treating malignant tumors, however, there is a lack of methods to evaluate its therapeutic efficacy. Herein, we investigated whether high mobility group box 1 (HMGB1) is a potential biomarker of BNCT res...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamichi, Shoji, Chen, Lichao, Ito, Tasuku, Tong, Ying, Onodera, Takae, Sasaki, Yuka, Nakamura, Satoshi, Mauri, PierLuigi, Sanada, Yu, Igaki, Hiroshi, Murakami, Yasufumi, Suzuki, Minoru, Itami, Jun, Masunaga, Shinichiro, Masutani, Mitsuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945761/
https://www.ncbi.nlm.nih.gov/pubmed/35336794
http://dx.doi.org/10.3390/biology11030420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945761/
https://www.ncbi.nlm.nih.gov/pubmed/35336794
http://dx.doi.org/10.3390/biology11030420

Ejemplares similares